Repare Therapeutics Inc. announced the appointment of Susan Molineaux, Ph.D., to its Board of Directors, effective as of the date of the Company's upcoming annual meeting of shareholders in June 2023. Concurrent with Dr. Molineaux's appointment as of the date of the annual meeting, Jerel Davis, Ph.D., Managing Director at Versant Ventures and a founding member of Repare's Board of Directors, will step down from the Board. Dr. Molineaux currently serves as President and Chief Executive Officer of Para Therapeutics Inc., a position she has held since April 2023.

Most recently, she served as President and Chief Executive Officer of Calithera Biosciences Inc., which she co-founded in March 2010. Prior to Calithera, she was a co-founder of Proteolix Inc., and served as Chief Scientific Officer before becoming President and Chief Executive Officer until the Company's acquisition by Onyx Pharmaceuticals Inc. in November 2009. Previously, she held various senior scientific and management positions including at Rigel Pharmaceuticals Inc. and Merck & Co.

Dr. Molineaux currently serves as a member of the Boards of Directors of Geron Corp., Cyteir Therapeutics Inc. and Smith College, and is a Scientific Advisor for Lightstone Ventures. Dr. Molineaux earned a B.S. in Biology from Smith College and a Ph.D. in Molecular Biology from Johns Hopkins University, and completed a postdoctoral fellowship at Columbia University.